SEC 13F Intelligence

Tobam / NVAX

Tobam’s Novavax Inc Position

Does Tobam own Novavax Inc (NVAX)? Not currently — the last reported position was 173.7K shares worth $13M in Q1 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$13M
Q1 2022
Shares
173.7K
% of Portfolio
+0.64%
Quarters Held
5
position exited

Position History NVAX

Reported value by quarter
Q1 ’21: $1MQ1 ’21Q2 ’21: $23MQ2 ’21Q3 ’21: $18MQ3 ’21Q4 ’21: $14MQ4 ’21Q1 ’22: $13MQ1 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2022173.7K$13M+0.64%
Q4 202194.7K$14M+0.61%
Q3 202187.8K$18M+0.77%
Q2 2021106.9K$23M+0.91%
Q1 20216.4K$1M+0.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tobam’s full portfolio or all institutional holders of NVAX.